Supraclavicular Versus Axillary Block for Arteriovenous (AV) Fistula Creation

Launched by SULTAN QABOOS UNIVERSITY · Mar 29, 2023

Keywords

ClinConnect Summary

This clinical trial is exploring two different methods of providing pain relief during a specific surgery known as arteriovenous (AV) fistula creation, which is often needed for patients undergoing dialysis. The study is comparing a technique called supraclavicular nerve block to another called axillary nerve block. Both methods will use the same numbing medicine and will be guided by ultrasound to ensure accuracy. A total of 120 patients will participate, with 60 receiving each type of nerve block. The goal is to see which method provides better pain relief, how much additional pain relief might be needed, and how quickly patients recover from the surgery.

To join the trial, participants must be at least 18 years old and be scheduled for AV fistula creation in a specific area of the arm. However, individuals who are not stable health-wise, have an infection where the needle will go, have certain bleeding disorders, or are allergic to the numbing medication cannot participate. Throughout the study, patients can expect close monitoring and support, and the researchers will review results partway through the trial to ensure everything is going well. This research is important as it aims to improve pain management options for patients undergoing this common procedure.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age \>18 years old
• • Patients undergoing AV fistula creation in the antecubital fossa
• Exclusion Criteria:
• • - Patient Refusal
• • Hemodynamically unstable patient
• • Local infection over the insertion site
• • Coagulopathy
• • Known allergy to Local Anaesthetic medications
• • Abnormal anatomy
• • Use of antiplatelet within 7 days of surgery